Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 28, 2025	Mar. 29, 2024
Cash flows from operating activities:
Net earnings	$ 954	$ 1,088
Noncash items:
Depreciation	181	179
Amortization of intangible assets	410	407
Amortization of acquisition-related inventory fair value step-up	0	25
Stock-based compensation expense	61	60
Pretax gain on sale of product line and investment losses	81	37
Impairment charges	15	0
Change in trade accounts receivable, net	89	516
Change in inventories	(166)	(118)
Change in trade accounts payable	(61)	(74)
Change in prepaid expenses and other assets	(32)	(21)
Change in accrued expenses and other liabilities	(233)	(360)
Net cash provided by operating activities	1,299	1,739
Cash flows from investing activities:
Payments for additions to property, plant and equipment	(245)	(291)
Proceeds from sales of property, plant and equipment	6	0
Payments for purchases of investments	(18)	(53)
Proceeds from sales of investments	5	9
Proceeds from sale of product line	9	0
All other investing activities	1	14
Total cash used in investing activities	(242)	(321)
Cash flows from financing activities:
Payments for the issuance of common stock in connection with stock-based compensation, net	(5)	(1)
Payment of dividends	(194)	(177)
Net borrowings (maturities longer than 90 days)	4	0
Net (repayments of) proceeds from borrowings (maturities of 90 days or less)	(3)	68
Payments for repurchase of common stock	(1,078)	0
All other financing activities	21	(23)
Total cash used in financing activities	(1,255)	(133)
Effect of exchange rate changes on cash and equivalents	113	(118)
Net change in cash and equivalents	(85)	1,167
Beginning balance of cash and equivalents	2,078	5,864
Ending balance of cash and equivalents	1,993	7,031
Supplemental disclosures:
Cash interest payments	63	42
Cash income tax payments	$ 201	$ 222